A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2704-2712

  Ashman, Jonathan B ^a   Miller, Jim ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN;

ALPHA HELIX; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL MEMBRANE; COMPLEX FORMATION; CROSS LINKING; GENE MUTATION; HYDROPHILICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL LINE; CELL MEMBRANE; CROSS-LINKING REAGENTS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; TRANSFECTION;

EID: 0033197960     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Marks, M. S., J. S. Blum, and P. Cresswell. 1990. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 111:839.
2. Lamb, C. A., and P. Cresswell. 1992. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148: 3478.
3. Bijlmakers, M.-j. E., P. Benaroch, and H. L. Ploegh. 1994. Mapping functional regions in the luminal domain of the class II-associated invariant chain. J. Exp. Med. 180:623.
4. Bertolino, P., M. Staschewski, M. C. Trescol-Biemont, I. M. Freisewinkel, K. Schenck, I. Chretien, F. Forquet, D. Gerlier, C. Rabourdin-Combe, and N. Koch. 1995. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation. J. Immunol. 154:5620.
5. Gedde-Dahl, M., I. Freisewinkel, M. Staschewski, K. Schenck, N. Koch, and O. Bakke. 1997. Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J. Biol. Chem. 272:8281.
6. Newcomb, J. R., and P. Cresswell. 1993. Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J. Immunol. 151:4153.
7. Amigorena, S., P. Webster, J. Drake, J. Newcomb, P. Cresswell, and I. Mellman. 1995. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 181:1729.
8. Jasanoff, A., G. Wagner, and D. C. Wiley. 1998. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. EMBO J 17:6812.
9. Anderson, K. S., and P. Cresswell. 1994. A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO J. 13:675.
10. Roche, P. A., M. S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392.
11. Freisewinkel, I. M., K. Schenck, and N. Koch. 1993. The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 90:9703.
12. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763.
13. Romagnoli, P., and R. N. Germain. 1994. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180:1107.
14. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
15. Morkowski, S., A. W. Goldrath, S. Eastman, L. Ramachandra, D. C. Freed, P. Whiteley, and A. Y. Rudensky. 1995. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediate. J. Exp. Med. 182:1403.
16. Stumptner, P., and P. Benaroch. 1997. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16:5807.
17. Siebenkotten, I. M., C. Carstens, and N. Koch. 1998. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. J. Immunol. 160:3355.
18. Thayer, W. P., L. Ignatowicz, D. A. Weber, and P. E. Jensen. 1999. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules. J. Immunol. 162:1502.
19. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
20. Bonnerot, C., M. S. Marks, P. Cosson, E. J. Robertson, E. K. Bikoff, R. N. Germain, and J. S. Bonafacino. 1994. Association with BiP and aggregation of class II molecules synthesized in the absence of invariant chain. EMBO J. 13:934.
21. Schaiff, W. T., K. A. Hruska, Jr., C. Bono, S. Shuman, and B. D. Schwarz. 1991. Invariant chain influences post-translational processing of HLA-DR molecules. J. Immunol. 147:603.
22. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
23. Zhong, G., F. Castellino, P. Romagnoli, and R. N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:2061.
24. Kropshofer, H., A. B. Vogt, and G. J. Hammerling. 1995. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. Proc. Natl. Acad. Sci. USA 92:8313.
25. Vogt, A. B., L. J. Stern, C. Amshoff, B. Dobberstein, G. J. Hämmerling, and H. Kropshofer. 1995. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol. 155:4757.
26. Karp, D. R., R. N. Jenkins, and E. O. Long. 1992. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc. Natl. Acad. Sci. USA 89:9657.
27. Wilson, N. A., P. Wolf, H. Ploegh, and L. Ignatowicz. 1998. Invariant chain can bind MHC class II at a site other than the peptide binding groove. J. Immunol. 161:4777.
28. Benaroch, P., M. Yilla, G. Raposo, K. Ito, K. Miwa, H. J. Geuze, and H. L. Ploegh. 1995. How MHC class II molecules reach the endocytic pathway. EMBO J. 14:37.
29. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
30. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. L. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600.
31. Pieters, J., O. Bakke, and B. Dobberstein. 1993. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J. Cell Sci. 106:831.
32. Anderson, M. S., K. Swier, L. Ameson, and J. Miller. 1993. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J. Exp. Med. 178:1959.
33. Ameson, L. S., and J. Miller. 1995. Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence. J. Cell Biol. 129:1217.
34. Odorizzi, C. G., I. S. Trowbridge, L. Xue, C. R. Hopkins, C. D. Davis, and J. F. Collawn. 1994. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol. 126:317.
35. Kang, S., L. Liang, C. D. Parker, and J. F. Collawn. 1998. Structural requirements for major histocompatibility complex class II invariant chain endocytosis and lysosomal targeting. J. Biol. Chem. 273:20644.
36. Odorizzi, G., and I. S. Trowbridge. 1997. Structural requirements for major histocompatibility complex class II invariant chain trafficking in polarized Madin-Darby canine kidney cells. J. Biol. Chem. 272:11757.
37. Simonsen, A., E. Stang, B. Bremnes, M. Røe, K. Prydz, and O. Bakke. 1997. Sorting of MHC class II molecules and the associated invariant chain (Ii) in polarized MDCK cells. J. Cell Sci. 110:597.
38. Miller, J., and R. N. Germain. 1986. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp. Med. 164: 1478.
39. Peterson, M., and I. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596.
40. Romagnoli, P., and R. N. Germain. 1995. Inhibition of invariant chain (Ii)-calnexin interaction results in enhanced degradation of Ii but does not prevent the assembly of αβIi complexes. J. Exp. Med. 182:2027.
41. Oi, V., P. Jones, J. Goding, L. Herzenberg, and L. Herzenberg. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr. Top. Microbiol. Immunol. 81:115.
42. Mehringer, J., M. Harris, C. Kindle, D. McCourt, and S. Cullen. 1991. Characterization of fragments of the murine Ia-associated invariant chain. J. Immunol. 146:920.
43. Koch, N., G. Hammerling, N. Tada, S. Kimura, and U. Hammerling. 1982. Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d, and k. Eur. J. Immunol. 12:909.
44. Lipp, J., and B. Dobberstein. 1986. The membrane-spanning segment of invariant chain (Ig) contains a potentially cleavable signal sequence. Cell 46:1103.
45. Lipp, J., and B. Dobberstein. 1988. Signal and membrane anchor functions overlap in the type II membrane protein IgCAT. J. Cell Biol. 106:1813.
46. Landolt-Marticorena, C., K. A. Williams, C. M. Deber, and R. A. F. Reithmeier. 1993. Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins. J. Mol. Biol. 229:602.
47. Munro, S. 1995. An investigation of the role of transmembrane domains in Golgi protein retention. EMBO J. 14:4695.
48. Bretscher, M. S., and S. Munro. 1993. Cholesterol and the Golgi apparatus. Science 261:1280.
49. Koch, N., and G. J. Hammerling. 1982. Structure of Ia antigens: identification of dimeric complexes formed by the invariant chain. J. Immunol. 128:1155.
50. Arunachalam, B., and P. Cresswell. 1995. Molecular requirements for the interaction of class II major histocompatibility complex molecules and invariant chain with calnexin. J. Biol. Chem. 270:2784.
51. Arunachalam, B., C. A. Lamb, and P. Cresswell. 1993. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int. Immunol. 6:439.
52. Park, S.-J., S. Sadegh-Nasseri, and D. C. Wiley. 1995. Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc. Natl. Acad. Sci. USA 92:11289.
53. Jasanoff, A., S.-J. Park, and D. C. Wiley. 1995. Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain. Proc. Natl. Acad. Sci. USA 92:9900.
54. De Planque, M. R. R., D. V. Greathouse, R. E. Koeppe, H. Schäfer, D. Marsh, and J. A. Killian. 1998. Influence of lipid/peptide hydrophobic mismatch on the thickness of diacylphosphatidylcholine bilayers: a 2H NMR and ESR study using designed transmembrane α-helical peptides and gramicidin A. Biochemistry 37: 9333.
55. Le Coutre, J., L. R. Narasimhan, C. Kumar, N. Patel, and H. R. Kaback. 1997. The lipid bilayer determines helical tilt angle and function in lactose permease of Escherichia coli. Proc. Natl. Acad. Sci. USA 94:10167.
56. Vonck, J. 1996. A three-dimensional difference map of the N intermediate in the bacteriorhodpsin reaction photocycle: part of the F-helix tilts in the M to N transition. Biochemistry 35:5870.
57. Weist, D. L., J. K. Burkhardt, S. Hester, M. Hortsch, D. I. Meyer, and Y. Argon. 1990. Membrane biogenesis during B cell differentiation: most endoplasmic reticulum proteins are expressed coordinately. J. Cell Biol. 110:1501.
58. Margolese, L., G. L. Waneck, C. K. Suzuki, E. Degen, R. A. Flavell, and D. B. Williams. 1993. Identification of the region on the class I histocompatibility molecule that interacts with the molecular chaperone, p88 (calnexin, IP90). J. Biol. Chem. 263:17959.
59. Ou, W. J., P. H. Cameron, D. Y. Thomas, and J. J. Bergeron. 1993. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364:771.
60. Hammond, C., I. Braakman, and A. Helenius. 1994. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc. Natl. Acad. Sci. USA 91:913.
61. Hebert, D. N., B. Foellmer, and A. Helenius. 1996. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J. 15:2961.
62. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505.
63. Bormann, B. J., W. J. Knowles, and V. T. Marchesi. 1989. Synthetic peptides mimic the assembly of transmembrane glycoproteins. J. Biol. Chem. 264:4033.
64. Lemmon, M. A., J. M. Flanagan, J. F. Hunt, B. D. Adair, B. J. Bormann, C. E. Dempsey, and D. M. Engelman. 1992. Glycophorin A dimerization is driven by specific interactions between transmembrane domain α-helices. J. Biol. Chem. 267:7683.
65. Kurosaki, T., I. Gander, and J. V. Ravetch. 1991. A subunit common to an IgG Fc receptor and the T-cell receptor mediates assembly through different interactions. Proc. Natl. Acad. Sci. USA 88:3837.
66. Manolios, N., J. S. Bonifacino, and R. D. Klausner. 1990. Transmembrane helical interactions and the assembly of the T cell receptor complex. Science 249:274.
67. Cosson, P., S. P. Lankford, J. S. Bonifacino, and R. D. Klausner. 1991. Membrane protein association by potential intramembrane charge pairs. Nature 351: 414.
68. Cosson, P., and J. S. Bonifacino. 1992. Role of transmembrane domain interactions in the assembly of class II MHC molecules. Science 258:659.
69. Doms, R. W., and A. Helenius. 1986. Quaternary structure of influenza virus hemagglutinin after acid treatment. J. Virol. 60:833.
70. Singh, I., R. W. Doms, K. R. Wagner, and A. Helenius. 1990. Intracellular transport of soluble and membrane-bound glycoproteins: folding, assembly and secretion of anchor-free influenza hemagglutinin. EMBO J. 9:631.
71. Kemble, G. W., Y. I. Henis, and J. M. White. 1993. GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J. Cell Biol. 122:1253.
72. Langosch, D., and J. Heringa. 1998. Interaction of transmembrane helices by a knobs-into-holes packing characteristic of soluble coiled coils. Proteins 31:150.
73. Lemmon, M. A., and D. M. Engelman. 1994. Specificity and promiscuity in membrane helix interactions. Q. Rev. Biophys. 27:157.
74. Oakley, M. G., and P. S. Kim. 1998. A buried polar residue can direct the relative orientation of helices in a coiled coil. Biochemistry 37:12603.
75. Eckert, D. M., V. N. Malashkevich, and P. S. Kim. 1998. Crystal structure of GCN4-pIQI, a trimeric coiled coil with buried polar residues. J. Mol. Biol. 284: 859.
76. Woolfson, D. N., and T. Alber. 1995. Predicting oligomerization states of coiled coils. Protein Sci. 4:1596.
77. Wolf, E., P. S. Kim, and B. Berger. 1997. MultiCoil: a program for predicting two and three-stranded coiled coils. Protein Sci. 6:1179.
78. Swift, A. M., and C. E. Machamer. 1991. A Golgi retention signal in a membrane-spanning domain of coronavirus E1 protein. J. Cell Biol. 115:19.
79. Weisz, O. A., A. M. Swift, and C. E. Machamer. 1993. Oligomerization of a membrane protein correlates with its retention in the Golgi complex. J. Cell Biol. 122:1185.
80. Klein, O., G. W. Polack, T. Surti, D. Kegler-Ebo, S. O. Smith, and D. DiMaio. 1998. Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor β receptor activation and cell transformation. J. Virol. 72:8921.
81. Gray, T. M., and B. W. Matthews. 1984. Intrahelical hydrogen bonding of serine, threonine and cysteine residues within α-helices and its relevance to membrane-bound proteins. J. Mol. Biol. 175:75.